Market Summary
USD71.20+0.82
Market Closed1.17%
THC Alerts
THC Stock Price
THC RSI Chart
THC Valuation
THC Price/Sales (Trailing)
THC Profitability
THC Fundamentals
THC Revenue
THC Earnings
Price Action
52 Week Range
36.6974.10
(Low)(High)
Last 7 days
1.3%
Last 30 days
-4.0%
Last 90 days
18.2%
Trailing 12 Months
6.0%
THC Financial Health
THC Investor Care
Peers (Alternatives to Tenet Healthcare)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
HCA | 72.9B | 60.9B | -8.06% | 22.94% | 12.72 | 1.2 | 1.94% | -15.77% |
LH | 20.7B | 14.8B | -6.52% | -17.34% | 16.22 | 1.39 | -6.96% | -52.35% |
DGX | 14.9B | 9.6B | -3.55% | -6.97% | 18.73 | 1.55 | -10.08% | -57.84% |
| MID-CAP | ||||||||
UHS | 9.9B | 13.6B | -12.63% | 5.29% | 14.64 | 0.74 | 5.04% | -26.87% |
DVA | 8.5B | 11.7B | 2.28% | -5.48% | 16.53 | 0.73 | 0.42% | -43.11% |
THC | 7.2B | 19.4B | -4.01% | 6.04% | 7.08 | 0.37 | 0.01% | -33.70% |
EHC | 6.1B | 4.4B | -4.71% | 18.34% | 22.47 | 1.4 | 8.15% | -30.89% |
SGRY | 4.6B | 2.6B | -8.02% | -9.34% | -50.32 | 1.77 | 13.01% | -143.24% |
SEM | 3.5B | 6.4B | -10.39% | 11.72% | 19.24 | 0.54 | 2.26% | -46.98% |
| SMALL-CAP | ||||||||
RDNT | 1.7B | 1.5B | 4.59% | 39.15% | -126.11 | 1.14 | 10.24% | -173.11% |
ADUS | 1.4B | 976.1M | 8.11% | 5.42% | 28.51 | 1.47 | 10.19% | 12.37% |
BKD | 645.6M | 2.9B | -20.05% | -40.55% | -3.53 | 0.22 | 7.97% | -101.02% |
CYH | 437.6M | 12.2B | -49.53% | -39.62% | -109.4 | 0.04 | -2.06% | -101.36% |
SSY | 6.7M | 46.8M | -8.63% | -12.62% | -2.44 | 0.14 | 12.07% | -154.21% |
Financials for Tenet Healthcare
| Income Statement (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
| Revenue | 1.4% | 19,450 | 19,174 | 19,040 | 19,133 | 19,449 |
| EBITDA | -6.0% | 3,075 | 3,272 | 3,671 | 3,743 | - |
| EBITDA Margin | -6.7% | 0.16* | 0.17* | 0.19* | 0.19* | - |
| Earnings Before Taxes | 0.1% | 1,346 | 1,344 | 1,551 | 1,945 | 1,999 |
| EBT Margin | -14.0% | 0.07* | 0.08* | 0.10* | 0.10* | - |
| Interest Expenses | -0.7% | 884 | 890 | 892 | 897 | 910 |
| Net Income | 1.6% | 1,017 | 1,001 | 1,146 | 1,456 | 1,534 |
| Net Income Margin | -13.3% | 0.05* | 0.06* | 0.08* | 0.08* | - |
| Free Cahsflow | 32.1% | 321 | 243 | 414 | 570 | - |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
| Assets | -0.3% | 27,067 | 27,156 | 27,076 | 26,621 | 26,650 |
| Current Assets | -1.9% | 5,869 | 5,981 | 5,998 | 6,064 | 6,128 |
| Cash Equivalents | -10.7% | 766 | 858 | 1,208 | 1,351 | 1,405 |
| Inventory | 0.5% | 407 | 405 | 394 | 387 | 391 |
| Goodwill | 1.3% | 10,258 | 10,123 | 9,979 | 9,479 | 84.00 |
| Liabilities | -1.3% | 22,262 | 22,548 | 22,501 | 22,510 | 22,236 |
| Current Liabilities | -5.7% | 4,219 | 4,476 | 4,276 | 4,368 | 4,668 |
| Long Term Debt | 0.0% | 14,935 | 14,934 | 14,962 | 14,947 | 14,719 |
| Shareholder's Equity | 8.0% | 1,233 | 1,142 | 1,235 | 2,114 | 2,056 |
| Retained Earnings | 17.8% | -660 | -803 | -905 | -1,036 | -1,074 |
| Additional Paid-In Capital | -0.1% | 4,774 | 4,778 | 4,771 | 4,756 | 4,765 |
| Shares Outstanding | -5.2% | 102 | 108 | 108 | 107 | - |
| Minority Interest | 2.3% | 1,347 | 1,317 | 1,272 | 1,027 | 1,000 |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
| Cashflow From Operations | 20.4% | 1,304 | 1,083 | 1,019 | 1,136 | 1,262 |
| Share Based Compensation | -3.6% | 54.00 | 56.00 | 60.00 | 60.00 | 58.00 |
| Cashflow From Investing | -28.0% | -1,034 | -808 | -2,018 | -719 | -629 |
| Cashflow From Financing | 49.0% | -909 | -1,781 | -85.00 | -1,260 | -1,369 |
| Buy Backs | -20.0% | 200 | 250 | 0.00 | - | - |
Risks for THC
What is the probability of a big loss on THC?
87.3%
Probability that Tenet Healthcare stock will be more than 20% underwater in next one year
71.2%
Probability that Tenet Healthcare stock will be more than 30% underwater in next one year.
66.2%
Probability that Tenet Healthcare stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does THC drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Tenet Healthcare was unfortunately bought at previous high price.
Drawdowns
Returns for THC
Cumulative Returns on THC
4.0%
10-Year Cumulative Returns
13.5%
7-Year Cumulative Returns
14.7%
5-Year Cumulative Returns
47.9%
3-Year Cumulative Returns
What are the long-term rolling returns for THC?
FIve years rolling returns for Tenet Healthcare.
Annualized Returns
Which funds bought or sold THC recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-05-26 | ProShare Advisors LLC | reduced | -22.48 | -22,622 | 382,189 | -% |
2023-05-23 | Brookfield Corp /ON/ | new | - | 1,776,540 | 1,776,540 | 0.01% |
2023-05-22 | AMERIPRISE FINANCIAL INC | added | 15.09 | 6,013,660 | 20,979,700 | 0.01% |
2023-05-22 | PUTNAM INVESTMENTS LLC | unchanged | - | 1,854,120 | 10,364,200 | 0.02% |
2023-05-18 | JPMORGAN CHASE & CO | reduced | -5.26 | 2,131,070 | 15,987,100 | -% |
2023-05-18 | NEW YORK STATE COMMON RETIREMENT FUND | added | 123 | 10,274,000 | 16,229,000 | 0.02% |
2023-05-17 | Advisory Services Network, LLC | unchanged | - | 8,738 | 48,843 | -% |
2023-05-17 | Thrivent Financial for Lutherans | reduced | -0.92 | 290,000 | 1,695,000 | -% |
2023-05-17 | VIRGINIA RETIREMENT SYSTEMS ET AL | added | 8.24 | 31,314 | 1,346,600 | 0.01% |
2023-05-17 | B. Riley Wealth Advisors, Inc. | reduced | -12.51 | 20,817 | 338,635 | 0.01% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
THC Alerts
Tenet Healthcare News
Schedule 13G FIlings of Tenet Healthcare
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Mar 08, 2023 | blackrock inc. | 11.2% | 11,498,067 | SC 13G/A | |
| Feb 14, 2023 | harris associates l p | 5.1% | 5,463,374 | SC 13G/A | |
| Feb 14, 2023 | glenview capital management, llc | 8.23% | 8,896,111 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 10.45% | 11,304,003 | SC 13G/A | |
| Feb 08, 2023 | invesco ltd. | 3.9% | 4,176,487 | SC 13G/A | |
| Jan 24, 2023 | blackrock inc. | 9.4% | 10,147,574 | SC 13G | |
| Feb 14, 2022 | glenview capital management, llc | 6.84% | 7,327,108 | SC 13G/A | |
| Feb 14, 2022 | invesco ltd. | 5.2% | 5,553,758 | SC 13G | |
| Feb 11, 2022 | harris associates l p | 5.6% | 6,000,495 | SC 13G/A | |
| Feb 10, 2022 | vanguard group inc | 10.13% | 10,855,165 | SC 13G/A |
Recent SEC filings of Tenet Healthcare
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| May 30, 2023 | 3 | Insider Trading | |
| May 30, 2023 | 8-K | Current Report | |
| May 30, 2023 | 4 | Insider Trading | |
| May 30, 2023 | 4 | Insider Trading | |
| May 30, 2023 | 4 | Insider Trading | |
| May 30, 2023 | 4 | Insider Trading | |
| May 30, 2023 | 4 | Insider Trading | |
| May 30, 2023 | 4 | Insider Trading | |
| May 30, 2023 | 4 | Insider Trading | |
| May 30, 2023 | 4 | Insider Trading |
Latest Insider Trading transactions for THC
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-05-19 | Arnst Thomas W | sold | -1,548,600 | 73.1231 | -21,178 | evp, chief admin. officer & gc |
2023-03-07 | Arnst Thomas W | sold | -96,112 | 60.07 | -1,600 | evp, chief admin. officer & gc |
2023-03-06 | Cancelmi Daniel J | acquired | - | - | 101,791 | evp & chief financial officer |
2023-03-06 | Arnst Thomas W | sold (taxes) | -656,354 | 58.9452 | -11,135 | evp, chief admin. officer & gc |
2023-03-06 | Ramsey R. Scott | sold (taxes) | -185,445 | 59.3995 | -3,122 | principal accounting officer |
2023-03-06 | Arnst Thomas W | sold | -50,325 | 61.00 | -825 | evp, chief admin. officer & gc |
2023-03-06 | Foo Lisa Y | acquired | - | - | 13,629 | evp, commercial ops |
2023-03-06 | Arnst Thomas W | acquired | - | - | 34,738 | evp, chief admin. officer & gc |
2023-03-06 | Foo Lisa Y | sold (taxes) | -275,162 | 59.4945 | -4,625 | evp, commercial ops |
2023-03-06 | Arbour Paola M | sold (taxes) | -698,116 | 59.3838 | -11,756 | evp, chief information officer |
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
THC Income Statement
2023-03-31CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | |
|---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
| Income Statement [Abstract] | ||
| Net operating revenues | $ 5,021 | $ 4,745 |
| Grant income | 3 | 6 |
| Equity in earnings of unconsolidated affiliates | 50 | 46 |
| Operating expenses: | ||
| Salaries, wages and benefits | 2,258 | 2,182 |
| Supplies | 891 | 785 |
| Other operating expenses, net | 1,093 | 942 |
| Depreciation and amortization | 217 | 203 |
| Impairment and restructuring charges, and acquisition-related costs | 21 | 16 |
| Litigation and investigation costs | 4 | 20 |
| Net losses (gains) on sales, consolidation and deconsolidation of facilities | (13) | 1 |
| Operating income | 603 | 648 |
| Interest expense | (221) | (227) |
| Other non-operating expense, net | (2) | 0 |
| Loss from early extinguishment of debt | 0 | (43) |
| Income from continuing operations, before income taxes | 380 | 378 |
| Income tax expense | (84) | (99) |
| Income from continuing operations, before discontinued operations | 296 | 279 |
| Discontinued operations: | ||
| Income from operations | 0 | 1 |
| Income from discontinued operations | 0 | 1 |
| Net income | 296 | 280 |
| Less: Net income available to noncontrolling interests | 153 | 140 |
| Net income available to Tenet Healthcare Corporation common shareholders | 143 | 140 |
| Amounts available to Tenet Healthcare Corporation common shareholders | ||
| Income from continuing operations, net of tax | 143 | 139 |
| Income from discontinued operations, net of tax | 0 | 1 |
| Net income available to Tenet Healthcare Corporation common shareholders | $ 143 | $ 140 |
| Basic | ||
| Continuing operations (in dollars per share) | $ 1.40 | $ 1.29 |
| Discontinued operations (in dollars per share) | 0 | 0.01 |
| Total earnings (loss) per share, basic (in dollars per share) | 1.40 | 1.30 |
| Diluted | ||
| Continuing operations (in dollars per share) | 1.32 | 1.27 |
| Discontinued operations (in dollars per share) | 0 | 0.01 |
| Total earnings (loss) per share, diluted (in dollars per share) | $ 1.32 | $ 1.28 |
| Weighted average shares and dilutive securities outstanding (in thousands): | ||
| Basic (in shares) | 102,289 | 107,483 |
| Diluted (in shares) | 106,006 | 112,020 |
THC Balance Sheet
2023-03-31CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 766 | $ 858 |
| Accounts receivable | 2,883 | 2,943 |
| Inventories of supplies, at cost | 407 | 405 |
| Assets held for sale | 142 | 0 |
| Other current assets | 1,671 | 1,775 |
| Total current assets | 5,869 | 5,981 |
| Investments and other assets | 3,175 | 3,147 |
| Deferred income taxes | 14 | 19 |
| Property and equipment, at cost, less accumulated depreciation and amortization ($6,225 at March 31, 2023 and $6,201 at December 31, 2022) | 6,319 | 6,462 |
| Goodwill | 10,258 | 10,123 |
| Other intangible assets, at cost, less accumulated amortization ($1,429 at March 31, 2023 and $1,428 at December 31, 2022) | 1,432 | 1,424 |
| Total assets | 27,067 | 27,156 |
| Current liabilities: | ||
| Current portion of long-term debt | 148 | 145 |
| Accounts payable | 1,192 | 1,504 |
| Accrued compensation and benefits | 602 | 778 |
| Professional and general liability reserves | 256 | 255 |
| Accrued interest payable | 248 | 213 |
| Liabilities held for sale | 23 | 0 |
| Contract liabilities | 76 | 110 |
| Other current liabilities | 1,674 | 1,471 |
| Total current liabilities | 4,219 | 4,476 |
| Long-term debt, net of current portion | 14,935 | 14,934 |
| Professional and general liability reserves | 810 | 790 |
| Defined benefit plan obligations | 330 | 331 |
| Deferred income taxes | 220 | 217 |
| Other long-term liabilities | 1,748 | 1,800 |
| Total liabilities | 22,262 | 22,548 |
| Commitments and contingencies | ||
| Redeemable noncontrolling interests in equity of consolidated subsidiaries | 2,225 | 2,149 |
| Shareholders’ equity: | ||
| Common stock, $0.05 par value; authorized 262,500,000 shares; 157,032,313 shares issued at March 31, 2023 and 156,462,456 shares issued at December 31, 2022 | 8 | 8 |
| Additional paid-in capital | 4,774 | 4,778 |
| Accumulated other comprehensive loss | (179) | (181) |
| Accumulated deficit | (660) | (803) |
| Common stock in treasury, at cost, 55,120,211 shares at March 31, 2023 and 54,215,871 shares at December 31, 2022 | (2,710) | (2,660) |
| Total shareholders’ equity | 1,233 | 1,142 |
| Noncontrolling interests | 1,347 | 1,317 |
| Total equity | 2,580 | 2,459 |
| Total liabilities and equity | $ 27,067 | $ 27,156 |